These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1480732)

  • 1. Transient neutropenia induced by clozapine.
    Hummer M; Kurz M; Barnas C; Fleischhacker WW
    Psychopharmacol Bull; 1992; 28(3):287-90. PubMed ID: 1480732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-induced transient white blood count disorders.
    Hummer M; Kurz M; Barnas C; Saria A; Fleischhacker WW
    J Clin Psychiatry; 1994 Oct; 55(10):429-32. PubMed ID: 7961519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia induced by second generation antipsychotics: a prospective investigation.
    Rettenbacher MA; Hofer A; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2010 Mar; 43(2):41-4. PubMed ID: 20175050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
    Alfaro J; Berdichevsky E; Conte G; Tellez C
    Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematological adverse events in clozapine-treated children and adolescents.
    Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A; Landry P; Deschamps R; Lessard M
    Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
    N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
    Maskasame S; Krisanaprakornkit T; Khiewyoo J
    J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
    McKee JR; Wall T; Owensby J
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does eosinophilia predict clozapine induced neutropenia?
    Hummer M; Sperner-Unterweger B; Kemmler G; Falk M; Kurz M; Oberbauer H; Fleischhacker WW
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):201-4. PubMed ID: 8935817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP
    Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine-induced eosinophilia: subsequent neutropenia and corresponding allergic mechanisms.
    Lucht MJ; Rietschel M
    J Clin Psychiatry; 1998 Apr; 59(4):195-7. PubMed ID: 9590673
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
    Schulte P
    Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of clozapine-induced granulocytopenia with lithium (two observations)].
    Papetti F; Darcourt G; Giordana JY; Spreux A; Thauby S; Feral F; Pringuey D
    Encephale; 2004; 30(6):578-82. PubMed ID: 15738861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do white-cell count spikes predict agranulocytosis in clozapine recipients?
    Alvir JM; Lieberman JA; Safferman AZ
    Psychopharmacol Bull; 1995; 31(2):311-4. PubMed ID: 7491384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adjunctive use of a centralised database in the monitoring of clozapine-related neutropenia.
    Pascoe SJ
    Pharmacoepidemiol Drug Saf; 2003; 12(5):395-8. PubMed ID: 12899114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.